{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:02:59Z","timestamp":1775019779209,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hebei Natural Science Foundation of China","award":["H2020206349"],"award-info":[{"award-number":["H2020206349"]}]},{"name":"the Research Fund of the Second Hospital of Hebei Medical University of China","award":["2h2019041"],"award-info":[{"award-number":["2h2019041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Wiskott\u2013Aldrich syndrome (WAS) is a rare X-linked immunodeficiency disorder caused by abnormal expression of the WAS protein (WASp) due to mutations in the<jats:italic>WAS<\/jats:italic>gene, and is generally characterized by microthrombocytopenia, eczema, recurrent infections, and high susceptibility to autoimmune complications and hematological malignancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Herein, we identified a novel<jats:italic>WAS<\/jats:italic>mutation (c.158\u00a0T\u2009&gt;\u2009C) using next-generation sequencing in a Chinese pedigree with WAS. The expression of WASp in the patients and their families was detected by flow cytometry and western blot analysis. To explore the exon-splicing effect of intron mutations and the correlation between the genotype and clinical phenotype, four groups of wild-type (WT), exon mutant, intron mutant, and combined mutant recombinant plasmids were transfected into COS-7 cells in vitro. The proband showed dramatically decreased WASp expression, while the female carriers showed a slightly lower level of WASp. The expression of products in the mutant and WT recombinant plasmids was detected by real-time fluorescence quantitative polymerase chain reaction (PCR), which showed a significant reduction in the combined mutant group than in the WT, exon mutant, and intron mutant groups. The length of the expression products in the four groups showed no differences, each containing 360 base pairs. Sequence analysis confirmed that the c.158\u00a0T\u2009&gt;\u2009C mutation appeared in the exon mutant and combined mutant groups, whereas the intron variant c.273\u2009+\u200914C\u2009&gt;\u2009T caused no other sequence changes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study confirmed that the intron mutation did not affect the splicing of exons and excluded the influence of the double mutations at the transcription level on the severe clinical manifestations in the cousin. This in vitro study provided new insights into the pathogenesis of intronic mutations in WAS.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-022-02589-y","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T15:03:18Z","timestamp":1671721398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of a novel WAS mutation and the non-splicing effect of a second-site mutation in a Chinese pedigree with Wiskott\u2013Aldrich syndrome"],"prefix":"10.1186","volume":"17","author":[{"given":"Xin","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuening","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-6720","authenticated-orcid":false,"given":"Jihong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"issue":"1","key":"2589_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10875-017-0453-z","volume":"38","author":"F Candotti","year":"2018","unstructured":"Candotti F. Clinical manifestations and pathophysiological mechanisms of the Wiskott\u2013Aldrich syndrome. J Clin Immunol. 2018;38(1):13\u201327.","journal-title":"J Clin Immunol"},{"issue":"9","key":"2589_CR2","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1182\/blood-2012-08-448118","volume":"121","author":"N Mahlaoui","year":"2013","unstructured":"Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nab\u00e9ra C, Moshous D, et al. Characteristics and outcome of early-onset, severe forms of Wiskott\u2013Aldrich syndrome. Blood. 2013;121(9):1510\u20136.","journal-title":"Blood"},{"issue":"1","key":"2589_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13256-016-0944-1","volume":"10","author":"MF Baharin","year":"2016","unstructured":"Baharin MF, Dhaliwal JS, Sarachandran SVV, Idris SZ, Yeoh SL. A rare case of Wiskott\u2013Aldrich syndrome with normal platelet size: a case report. J Med Case Rep. 2016;10(1):188.","journal-title":"J Med Case Rep"},{"issue":"3","key":"2589_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/MPH.0000000000000949","volume":"40","author":"MA Karalexi","year":"2018","unstructured":"Karalexi MA, Tzanoudaki M, Fryganas A, Gkergki A, Spyropoulou D, Papadopoulou A, et al. Wiskott\u2013Aldrich syndrome misdiagnosed as immune thrombocytopenic purpura: a case report. J Pediatr Hematol Oncol. 2018;40(3):240\u20132.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2589_CR5","doi-asserted-by":"crossref","unstructured":"Kaneko R, Yamamoto S, Okamoto N, Akiyama K, Matsuno R, Toyama D, et al. Wiskott\u2013Aldrich syndrome that was initially diagnosed as immune thrombocytopenic purpura secondary to a cytomegalovirus infection. SAGE. Open Med Case Rep. 2018;6:2050313X17753788.","DOI":"10.1177\/2050313X17753788"},{"issue":"23","key":"2589_CR6","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1182\/blood.2019002939","volume":"135","author":"L Burroughs","year":"2020","unstructured":"Burroughs L, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, et al. Excellent outcomes following hematopoietic cell transplantation for Wiskott\u2013Aldrich syndrome: A PIDTC report. Blood. 2020;135(23):2094\u2013105.","journal-title":"Blood"},{"issue":"25","key":"2589_CR7","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0960-9822(98)00015-3","volume":"8","author":"LM Machesky","year":"1998","unstructured":"Machesky LM, Insall RH. Scar1 and the related Wiskott\u2013Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2\/3 complex. Curr Biol. 1998;8(25):1347\u201356.","journal-title":"Curr Biol"},{"issue":"11","key":"2589_CR8","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/eji.201646715","volume":"47","author":"E Rivers","year":"2017","unstructured":"Rivers E, Thrasher AJ. Wiskott\u2013Aldrich syndrome protein: Emerging mechanisms in immunity. Eur J Immunol. 2017;47(11):1857\u201366.","journal-title":"Eur J Immunol"},{"issue":"4","key":"2589_CR9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jaci.2011.01.015","volume":"127","author":"MJ Massaad","year":"2011","unstructured":"Massaad MJ, Ramesh N, Le Bras S, Giliani S, Notarangelo LD, Al-Herz W, et al. A peptide derived from the Wiskott\u2013Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding. J Allergy Clin Immunol. 2011;127(4):998\u20131005.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2589_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WAS gene mutations. Blood. 2004;103(2):456\u201364.","journal-title":"Blood"},{"issue":"13","key":"2589_CR11","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott\u2013Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood. 2004;104(13):4010\u20139.","journal-title":"Blood"},{"issue":"3\u20134","key":"2589_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1155\/2010\/781523","volume":"29","author":"MP Blundell","year":"2010","unstructured":"Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott\u2013Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers. 2010;29(3\u20134):157\u201375.","journal-title":"Dis Markers"},{"issue":"2","key":"2589_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MPH.0000000000000479","volume":"38","author":"K Howard","year":"2016","unstructured":"Howard K, Hall CP, Al-Rahawan MM. Wiskott\u2013Aldrich syndrome: description of a new gene mutation without immunodeficiency. J Pediatr Hematol Oncol. 2016;38(2):163.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"2589_CR14","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1182\/blood.V90.7.2680","volume":"90","author":"Q Zhu","year":"1997","unstructured":"Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, et al. Wiscott\u2013Aldrich syndrome\/X-linked thrombocytopenia: WAS gene mutations, protein expression, and phenotype. Blood. 1997;90(7):2680\u20139.","journal-title":"Blood"},{"issue":"1\u20133","key":"2589_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12026-008-8084-3","volume":"44","author":"HD Ochs","year":"2009","unstructured":"Ochs HD. Mutations of the Wiskott\u2013Aldrich syndrome protein affect protein expression and dictate the clinical phenotypes. Immunol Res. 2009;44(1\u20133):84\u20138.","journal-title":"Immunol Res"},{"issue":"1","key":"2589_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MOH.0b013e32834114bc","volume":"18","author":"MH Albert","year":"2011","unstructured":"Albert MH, Notarangelo LD, Ochs HD. Clinical spectrum, pathophysiology and treatment of the Wiskott\u2013Aldrich syndrome. Curr Opin Hematol. 2011;18(1):42\u20138.","journal-title":"Curr Opin Hematol"},{"issue":"9","key":"2589_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/pbc.25559","volume":"62","author":"DW Liu","year":"2015","unstructured":"Liu DW, Zhang ZY, Zhao Q, Jiang LP, Liu W, Tu WW, et al. Wiskott\u2013Aldrich syndrome\/X-linked thrombocytopenia in China: clinical characteristic and genotype-phenotype correlation. Pediatr Blood Cancer. 2015;62(9):1601\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2589_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nri2724","volume":"10","author":"AJ Thrasher","year":"2010","unstructured":"Thrasher AJ, Burns SO. WAS: a key immunological multitasker. Nat Rev Immunol. 2010;10(3):182\u201392.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2589_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12887-017-0897-6","volume":"17","author":"SS Medina","year":"2017","unstructured":"Medina SS, Siqueira LH, Colella MP, Yamaguti-Hayakawa GG, Duarte BKL, Dos Santos Vilela MM, et al. Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott\u2013Aldrich syndrome protein. BMC Pediatr. 2017;17(1):151.","journal-title":"BMC Pediatr"},{"issue":"3","key":"2589_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0009922810385676","volume":"50","author":"N Bryant","year":"2011","unstructured":"Bryant N, Watts R. Thrombocytopenic syndromes masquerading as childhood immune thrombocytopenic purpura. Clin Pediatr. 2011;50(3):225\u201330.","journal-title":"Clin Pediatr"},{"key":"2589_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","volume":"1285","author":"MJ Massaad","year":"2013","unstructured":"Massaad MJ, Ramesh N, Geha RS. Wiskott\u2013Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci. 2013;1285:26\u201343.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2589_CR22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1189\/jlb.5MR0617-257R","volume":"103","author":"L Sereni","year":"2018","unstructured":"Sereni L, Castiello MC, Villa A. Platelets in Wiskott\u2013Aldrich syndrome: victims or executioners? J Leukoc Biol. 2018;103(3):577\u201390.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2589_CR23","first-page":"463","volume":"21","author":"C Liu","year":"2019","unstructured":"Liu C, Chen XY, Wu WQ, An WB, Chang LX, Lan Y, et al. Clinical features of Wiskott\u2013Aldrich syndrome: an analysis of 13 cases. Zhong Guo Dang Dai Er Ke Za Zhi. 2019;21(5):463\u20137.","journal-title":"Zhong Guo Dang Dai Er Ke Za Zhi"},{"issue":"2","key":"2589_CR24","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1097\/MPH.0000000000001790","volume":"43","author":"E Ochfeld","year":"2021","unstructured":"Ochfeld E, Grayer D, Sharma R, Schneiderman J, Giordano L, Makhija M. A novel mutation in WAS gene causing a phenotypic presentation of Wiskott\u2013Aldrich syndrome: a case report. J Pediatr Hematol Oncol. 2021;43(2):e234\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2589_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/humu.9013","volume":"19","author":"J El-Hakeh","year":"2002","unstructured":"El-Hakeh J, Rosenzweig S, Oleastro M, Basack N, Berozdnik L, Molina F, et al. Wiskott\u2013Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations. Hum Mutat. 2002;19(2):186\u20137.","journal-title":"Hum Mutat"},{"issue":"4","key":"2589_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<386::AID-HUMU24>3.0.CO;2-1","volume":"15","author":"RA Brooimans","year":"2000","unstructured":"Brooimans RA, van den Berg AJ, Tamminga RY, Revesz T, Wulffraat NM, Zegers BJ. Identification of six novel WASP gene mutations in patients suffering from Wiskott\u2013Aldrich syndrome. Hum Mutat. 2000;15(4):386\u20137.","journal-title":"Hum Mutat"},{"issue":"4","key":"2589_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ng0495-414","volume":"9","author":"A Villa","year":"1995","unstructured":"Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, et al. X-linked thrombocytopenia and Wiskott\u2013Aldrich syndrome are allelic diseases with mutations in the WAS gene. Nat Genet. 1995;9(4):414\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"2589_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/pbc.24787","volume":"61","author":"T Wada","year":"2014","unstructured":"Wada T, Itoh M, Maeba H, Toma T, Niida Y, Saikawa Y, et al. Intermittent X-linked thrombocytopenia with a novel WAS gene mutation. Pediatr Blood Cancer. 2014;61(4):746\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2589_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41431-018-0291-3","volume":"27","author":"E Shvetsova","year":"2019","unstructured":"Shvetsova E, Sofronova A, Monajemi R, Gagalova K, Draisma HHM, White SJ, et al. Skewed X-inactivation is common in the general female population. Eur J Hum Genet. 2019;27(3):455\u201365.","journal-title":"Eur J Hum Genet"},{"key":"2589_CR30","doi-asserted-by":"crossref","unstructured":"Stewart DM, Candotti F, Nelson DL. The phenomenon of spontaneous genetic reversions in the Wiskott\u2013Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4\u20137, 2006. J Clin Immunol. 2007;27(6):634\u20139.","DOI":"10.1007\/s10875-007-9121-z"},{"issue":"9","key":"2589_CR31","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1172\/JCI15485","volume":"111","author":"T Wada","year":"2003","unstructured":"Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, et al. Second-site mutation in the Wiskott\u2013Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest. 2003;111(9):1389\u201397.","journal-title":"J Clin Invest"},{"issue":"3","key":"2589_CR32","first-page":"158","volume":"1317","author":"T Ariga","year":"1996","unstructured":"Ariga T, Yamada M, Pudua FR, Sakiyama Y. Detection of a novel splice-site mutation that results in skipping exon 3 of the WAS gene in a patient with Wiskott\u2013Aldrich syndrome. Biochem Biophys Acta. 1996;1317(3):158\u201360.","journal-title":"Biochem Biophys Acta"},{"issue":"1","key":"2589_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jaci.2014.06.025","volume":"135","author":"J Wu","year":"2015","unstructured":"Wu J, Liu D, Tu W, Song W, Zhao X. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott\u2013Aldrich syndrome. J Allergy Clin Immunol. 2015;135(1):209\u201316.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2589_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2177\/jsci.37.447","volume":"37","author":"T Wada","year":"2014","unstructured":"Wada T. Revertant somatic mosaicism in primary immunodeficiency diseases. Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):447\u201353.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"2","key":"2589_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1517\/14712598.8.2.181","volume":"8","author":"A Galy","year":"2008","unstructured":"Galy A, Roncarolo MG, Thrasher AJ. Development of lentiviral gene therapy for Wiskott\u2013Aldrich syndrome. Expert Opin Biol Ther. 2008;8(2):181\u201390.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"2589_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1399-3038.2010.00996.x","volume":"21","author":"ZY Zhang","year":"2010","unstructured":"Zhang ZY, Xiao HQ, Jiang LP, Zhou Y, Zhao Q, Yu J, et al. Analysis of clinical and molecular characteristics of Wiskott\u2013Aldrich syndrome in 24 patients from 23 unrelated Chinese families. Pediatr Allergy Immunol. 2010;21(3):522\u201332.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"2589_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaci.2013.03.046","volume":"132","author":"Y Watanabe","year":"2013","unstructured":"Watanabe Y, Sasahara Y, Ramesh N, Massaad MJ, Looi CY, Kumaki S, et al. T-cell receptor ligation causes Wiskott\u2013Aldrich syndrome protein degradation and F-actin assembly downregulation. J Allergy Clin Immunol. 2013;132(3):648\u201355.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2589_CR38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3346\/jkms.2007.22.6.998","volume":"22","author":"SK Park","year":"2007","unstructured":"Park SK, Kim CS, Song DK, Kim JY, Choi IJ, Kim DK. A familial case of Wiskott\u2013Aldrich syndrome with a hotspot mutation in exon 2 of the WAS Gene. J Korean Med Sci. 2007;22(6):998\u20131001.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"2589_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/hae.12964","volume":"22","author":"SK Westbury","year":"2016","unstructured":"Westbury SK, Mumford AD. Genomics of platelet disorders. Haemophilia. 2016;22(5):20\u20134.","journal-title":"Haemophilia"},{"issue":"2","key":"2589_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/humu.9048","volume":"20","author":"KW Chan","year":"2002","unstructured":"Chan KW, Lee TL, Chung BH, Yang X, Lau YL. Identification of five novel WAS mutations in Chinese families with Wiskott\u2013Aldrich syndrome. Hum Mutat. 2002;20(2):151\u20132.","journal-title":"Hum Mutat"},{"issue":"6","key":"2589_CR41","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1182\/blood.V83.6.1542.1542","volume":"83","author":"L Hilbert","year":"1994","unstructured":"Hilbert L, Gaucher C, de Romeuf C, Horellou MH, Vink T, et al. Leu 697\u2013>Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood. 1994;83(6):1542\u201350.","journal-title":"Blood"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02589-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T20:44:44Z","timestamp":1679172284000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02589-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2589"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02589-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with the ethical standard of the Research Ethics Committee of the Second Hospital of Hebei Medical University. Informed consent was obtained from the patients\u2019 parents, legal guardians and family members before enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}